AJP - Heart and Circulatory Physiology, Vol 271, Issue 5 1878-H1883, Copyright © 1996 by American Physiological Society

ARTICLES

Neuropeptide Y reduces macromolecule permeability of coronary endothelial monolayers

T. Noll, A. Hempel and H. M. Piper
Physiologisches Institut, Justus-Liebig-Universitat, Giessen, Germany.

The effect of neuropeptide Y (NPY) on cellular adenosine 3',5'-cyclic monophosphate (cAMP) contents and macromolecule permeability was studied in cultured monolayers of microvascular coronary endothelial cells from rat. Macromolecule permeability was continuously determined as passage of albumin across the monolayers. NPY (10(-10)-10(-7) M) decreased albumin flux and cellular cAMP content in a dose-dependent manner, with a half-maximal effect on albumin flux at 1.4 x 10(-9) M and on cAMP contents at 0.7 x 10(-9) M. A maximum effect of NPY was observed at 10(-7) M, decreasing albumin flux by 71 +/- 8% and cellular cAMP contents by 80 +/- 9% (mean +/- SD, n = 6, P < 0.05) compared with control. The effect of NPY on albumin flux was not altered in the presence of 10(-5) M indomethacin (an inhibitor of cyclooxygenase) and 10(-5) M NG-nitro-L-arginine (an inhibitor of nitric oxide synthase). NPY (10(-7) M) also antagonized the increase of albumin flux and cAMP content induced by 10(-6) M isoproterenol. Pretreatment of endothelial monolayers with pertussis toxin (1 microgram/ml for 2 h) abolished the effect of NPY on albumin flux and cAMP contents. This study shows that NPY can modulate macromolecule permeability of endothelial monolayers by reducing the cellular cAMP contents. Together with the effect of pertussis toxin, the data suggest that NPY exerts its antiadrenergic effect on cAMP metabolism and endothelial barrier function by receptors linked to adenylyl cyclase via an inhibitory guanosine-binding protein in coronary endothelial cells.

This article has been cited by other articles:

				K. Bindewald, D. Gunduz, F. Hartel, S. C. Peters, C. Rodewald, S. Nau, M. Schafer, J. Neumann, H. M. Piper, and T. Noll Opposite effect of cAMP signaling in endothelial barriers of different origin Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1246 - C1255. [Abstract] [Full Text] [PDF]

				N. Kurimoto, Y.-S. Nan, Z.-Y. Chen, G.-G. Feng, T. Komatsu, N. Kandatsu, J. Ko, N. Kawai, and N. Ishikawa Effects of specific signal transduction inhibitors on increased permeability across rat endothelial monolayers induced by neuropeptide Y or VEGF Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H100 - H106. [Abstract] [Full Text] [PDF]

				Y.-S. Nan, G.-G. Feng, Y. Hotta, K. Nishiwaki, Y. Shimada, A. Ishikawa, N. Kurimoto, T. Shigei, and N. Ishikawa Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H1027 - H1033. [Abstract] [Full Text] [PDF]

				J. Knapp, P. Bokník, I. Lüss, S. Huke, B. Linck, H. Lüss, F. U. Müller, T. Müller, P. Nacke, T. Noll, et al. The Protein Phosphatase Inhibitor Cantharidin Alters Vascular Endothelial Cell Permeability J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1480 - 1486. [Abstract] [Full Text]

				T. Noll, H. Holschermann, K. Koprek, D. Gunduz, W. Haberbosch, H. Tillmanns, and H. M. Piper ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1892 - H1901. [Abstract] [Full Text] [PDF]

				A. Hempel, T. Noll, C. Bach, H. M. Piper, R. Willenbrock, K. Hohnel, H. Haller, and F. C. Luft Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1818 - H1825. [Abstract] [Full Text] [PDF]

				L. F. Richard, T. E. Dahms, and R. O. Webster Adenosine prevents permeability increase in oxidant-injured endothelial monolayers Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H35 - H42. [Abstract] [Full Text] [PDF]